Mednax President of Pediatrix and Obstetrix Medical Group Roger Mack Hinson to step down effective June 1, 2022

Pediatrix Medical Group, Inc.

Dr. Hinson will transition from his role as President effective June 1, 2022.
Termination is without 'Cause' under his Amended and Restated Employment Agreement.
Company and Dr. Hinson intend to enter a consulting agreement for advisory services post-transition.
No replacement for the President role has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Roger Mack Hinson

President of the Company’s Pediatrix and Obstetrix Medical Group

MD · Pediatrix Medical Group, Inc.

Effective: 2022-06-01
Filed: February 25, 2022, 6:59 PM ET

On February 23, 2022, Mednax, Inc., a Florida corporation (the “Company”), announced that Roger Mack Hinson, M.D., President of the Company’s Pediatrix and Obstetrix Medical Group, would transition from such position, effective as of June 1, 2022 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Roger Mack Hinson changed role as President of the Company’s Pediatrix and Obstetrix Medical Group at Pediatrix Medical Group, Inc..

Action: transitioned
Role: President of the Company’s Pediatrix and Obstetrix Medical Group

Exact text from the filing

On February 23, 2022, Mednax, Inc., a Florida corporation (the “Company”), announced that Roger Mack Hinson, M.D., President of the Company’s Pediatrix and Obstetrix Medical Group, would transition from such position, effective as of June 1, 2022 (the “Effective Date”).

View on SEC.gov

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-002114

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.